Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Dec 22, 2020 2:47pm
155 Views
Post# 32162434

RE:RE:Inhaled Vaccine

RE:RE:Inhaled Vaccine Like Silicon, graphene will be facing "big" challenges ahead in not only proving its safety in the human body, but also in convincing the medical community to use it...even if proven safe.  Thankfully, PDT is light years ahead in proven safety & acceptance.

BTW, I knew doc was onto something regarding potential delivery mechanisms for TLT's compound...

"Delivery mechanisms like a dry powder inhaler or nasal spray would maximize local concentrations directly at the site of infection and avoid having to administer it systemically (orally or parenterally).  Most antimicrobial agents currently used to treat common upper respiratory tract infections such as acute and chronic sinusitis achieve poor concentrations in the sinuses when administered systemically."


<< Previous
Bullboard Posts
Next >>